Montauk Renewables (MNTK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual meeting scheduled for May 26, 2026, to be held virtually, with record date set as April 2, 2026.
Strategic progress in 2025 included increased RNG production at Pico and Apex facilities, and the GreenWave joint venture generated $1.5 million in income.
Commissioning of the Turkey, North Carolina facility began in 2026, with a $200 million capital investment and new $200 million Senior Credit Facility secured.
Five-year gas rights extension negotiated for the Raeger RNG facility.
Voting matters and shareholder proposals
Shareholders will vote on the election of two Class III directors for three-year terms and ratification of Grant Thornton LLP as independent auditor for 2026.
Board recommends voting FOR both director nominees and auditor ratification.
Voting instructions differ for Nasdaq and JSE shareholders; proxy materials are available online.
Board of directors and corporate governance
Board consists of six members divided into three staggered classes; two Class III directors up for election.
Board leadership is separated between CEO and Chairman, with an independent Lead Director.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Environmental, Safety and Corporate Responsibility (ESCR).
Controlled company exemption applies due to over 50% ownership by parties to a Consortium Agreement.
Board and committee meeting attendance exceeded 75% for all directors in 2025.
Latest events from Montauk Renewables
- Vote on two director nominees and auditor ratification at the May 2026 virtual Annual Meeting.MNTK
Proxy filing10 Apr 2026 - Net income plunged on flat revenue as RIN prices fell, but 2026 guidance expects growth.MNTK
Q4 202512 Mar 2026 - Q2 revenue dropped 18.6% on delayed RIN sales, but 2024 guidance and project pipeline remain strong.MNTK
Q2 20241 Feb 2026 - Q3 2024 revenue up 18.4% and net income up 31.8%, but project delays persist.MNTK
Q3 202414 Jan 2026 - Net income fell 34.9% to $9.7M on flat revenue, with 2025 RNG revenue guidance at $150–$170M.MNTK
Q4 202426 Dec 2025 - Director elections, auditor ratification, and strategic growth initiatives highlight the 2025 meeting.MNTK
Proxy Filing1 Dec 2025 - Shareholders to elect two directors and ratify Grant Thornton LLP as auditor at the annual meeting.MNTK
Proxy Filing1 Dec 2025 - Revenue up 9.8%, but net loss and regulatory delays challenge outlook; major capex planned.MNTK
Q1 202526 Nov 2025 - Q2 2025 revenue rose 4.1% but net loss widened on lower RIN prices and higher costs.MNTK
Q2 202523 Nov 2025